Filter posts

BIO Reacts to Supreme Court opinion in Impression Products, Inc. v. Lexmark International, Inc.

On Tuesday, May 30, 2017, the U.S. Supreme Court issued an opinion in  Impression Products, Inc. …

ICYMI: Jim Greenwood’s Letter in NYT on Drug Importation

Yesterday, the New York Times published a letter to the editor from BIO’s President and …

World AIDS Day:
Untreatable to Beatable

I was just starting my first year in the Pennsylvania General Assembly in 1981 when …

BIO Principles Put Patients First

Patient advocacy organizations play an indispensable role in the biopharmaceutical development process: They help scientists …

BIO2016 Keynote Videos: Jim Greenwood and Ron Cohen

In case you missed it, below are the keynote remarks from BIO President & CEO, …

My Keynote Address at the 2016 BIO International Convention

Yesterday, the voters of California had their say. The general election is upon us. It’s …

A Closer Look at AHIP’s Claims

This morning, in a letter to the editor of the New York Times, Marilyn Tavenner, …

Jim Greenwood on "Time is Precious"

Jim Greenwood, President & CEO, Biotechnology Innovation Organization discusses the organizations new campaign, Time is …

Jim Greenwood in New York Times: Specialty Tiers Limit Patient Access

Today, the New York Times published a letter from Jim Greenwood, BIO’s President and CEO. …

Jim Greenwood on the Road: Opening Bell at NASDAQ

Jim Greenwood, BIO’s President and CEO, rang the opening bell this morning at the NASDAQ …